Ursolic Acid.

Maslinic acid and ursolic acid are both pentacyclic triterpenes from plant surface waxes and converge on AMPK signalling and proteasome activity. They co-occur naturally in olive and apple skin.

Corosolic acid is 2-alpha-hydroxyursolic acid, the same skeleton with one added hydroxyl, and both raise AMPK-linked GLUT4 translocation in muscle cells. Stacking them loads one pathway rather than two.

Rosemary leaf is one of the richest culinary sources of ursolic acid alongside its diterpene phenolics. A rosemary extract in the same formula already contributes to the triterpene load.

Ocimum sanctum leaf carries ursolic acid as one of its characteristic triterpenes. Formulating both raises exposure to the same compound from two directions.

Apple peel wax is the classic dietary source from which ursolic acid was first isolated in quantity. Whole apple material contributes the same molecule at food-level concentration.

Ursolic acid is highly lipophilic with very low aqueous solubility, so uptake depends on partitioning into a lipid phase and then into mixed micelles. A medium-chain lipid carrier raises the fraction that reaches the enterocyte.

Phosphatidylcholine forms the phospholipid complexes and micelles that carry poorly soluble triterpenes across the unstirred water layer. This is the same phytosome principle used for curcumin and silybin.

Complexing a lipophilic plant molecule with phosphatidylcholine gives an amphipathic particle that disperses in the gut and merges with the enterocyte membrane. It addresses solubility rather than metabolism.

Piperine slows UDP-glucuronosyltransferase conjugation and inhibits intestinal P-glycoprotein efflux, both of which limit systemic exposure to lipophilic plant molecules. It raises exposure without changing the target.

Berberine raises the cellular AMP to ATP ratio through mild complex I inhibition, activating AMPK, the same kinase ursolic acid signals through. Stacked, the effect on that node is additive rather than complementary.

EGCG activates AMPK and modulates the same downstream acetyl-CoA carboxylase step that ursolic acid influences. The two overlap on one signalling node.

Resveratrol raises AMPK activity and favours SIRT1 deacetylation, converging with ursolic acid on cellular energy sensing. Both are also poorly soluble and share the same absorption constraints.

Leucine signals through Rag GTPases to activate mTORC1 while ursolic acid raises IGF-1 and Akt signalling upstream of the same complex in skeletal muscle. They enter the pathway at different points.

HMB lowers ubiquitin-proteasome mediated protein breakdown while ursolic acid pushes the Akt side of protein synthesis signalling. The pairing addresses both directions of the same balance.

Quercetin is a heavy substrate for UDP-glucuronosyltransferase and sulfotransferase and saturates those enzymes, which raises exposure to other polyphenols and triterpenes handled by the same routes. The interaction is metabolic rather than at the target.

Whey delivers a leucine-rich amino acid stimulus that drives muscle protein synthesis after loading. The human ursolic acid trials measured markers of muscle damage and metabolic markers during resistance training rather than protein accretion. The pairing puts a substrate input beside a signalling input and has not been measured as a combination.

Creatine buffers ATP resynthesis during short high-intensity efforts through the phosphocreatine system. Ursolic acid has been studied for markers of muscle damage during resistance training. They act on different steps of the training response and the combination has not been tested.

Both compounds are reported to increase AMPK phosphorylation in preclinical work, which shifts cells toward catabolic energy handling. Alpha-lipoic acid also serves as a dehydrogenase cofactor. The overlap is on a signalling node observed in animal and cell studies, not in human co-administration data.

Ursolic acid and curcumin are both practically insoluble in water and both are typically presented in phospholipid or lipid-carrier systems. Placing them in one lipid base is efficient formulation rather than a pharmacological interaction. Their reported anti-inflammatory signalling overlaps but has not been measured together in people.

Tocopherols protect the oil phase of a lipid-based formulation from peroxidation during shelf life. Ursolic acid is usually carried in such a phase because of its solubility. The role here is formulation stability, not a biological synergy.

Animal work reports that ursolic acid raises AMPK-regulated autophagy in liver tissue under a high-fat load, and silymarin is studied for hepatic lipid handling from a different angle. Both bodies of evidence are preclinical for this endpoint. Read the pairing as mechanistic, and note that elevated liver fat markers are markers, not outcomes.

Both have been examined for effects on fasting glucose and insulin signalling markers, ursolic acid largely in rodents. Anyone already managing blood sugar with medical supervision should account for a possible additive direction. The evidence for the pair itself is absent.

Chromium is studied for its role in insulin receptor signalling, and preclinical ursolic acid work reports changes in the PI3K-AKT arm of that same cascade. The two could push in the same direction on glucose handling. No combination study exists, and the ursolic acid data on this pathway are from animals.

Boswellic acids and ursolic acid are both pentacyclic triterpene acids, poorly water soluble and usually delivered with a lipid or phospholipid carrier. Their reported signalling targets in inflammation research partly overlap. This is a chemical-class observation rather than a tested combination.

Vitamin D receptor signalling in muscle influences myocyte differentiation and calcium handling. Ursolic acid has been studied for muscle mass preservation in animal models through the PI3K-AKT-mTOR arm. The two act through separate receptors and have not been co-administered in published human work.

Several ursolic acid readouts in preclinical work run through transient increases in reactive oxygen species that act as signals rather than damage. A large thiol antioxidant load can blunt redox-mediated signalling of this kind. This is a mechanistic consideration drawn from the antagonistic co-occurrence flag, not a measured interaction in people.

Ursolic acid dissolves in triglyceride but not water, so a fish oil base can serve as the carrier phase in a soft gel. The interaction is physical dispersion. Any shared anti-inflammatory signalling is separate and untested as a pair.